Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,029 | 115 | 99.3% |
| Education | $14.31 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $196.47 | 12 | $0 (2024) |
| PFIZER INC. | $165.41 | 9 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $161.93 | 10 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $148.46 | 7 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $144.66 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $133.32 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $131.77 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $105.15 | 7 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $99.43 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $90.17 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $879.54 | 46 | Kiniksa Pharmaceuticals International, plc ($128.22) |
| 2023 | $609.31 | 36 | Merck Sharp & Dohme LLC ($87.88) |
| 2022 | $360.38 | 20 | Actelion Pharmaceuticals US, Inc. ($74.99) |
| 2021 | $193.87 | 14 | Novartis Pharmaceuticals Corporation ($62.70) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: CNS | ||||||
| 09/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Not Applicable | ||||||
| 08/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Celgene Corporation | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Cardiovascular | ||||||
| 07/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.54 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: Cardiovascular | ||||||
| 07/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardio-renal | ||||||
| 06/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/05/2024 | Celgene Corporation | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Cardiovascular | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/28/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Not Applicable | ||||||
| 05/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardio-renal | ||||||
| 05/22/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 05/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/01/2024 | Celgene Corporation | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 725 | 984 | $155,401 | $42,223 |
| 2022 | 12 | 698 | 1,009 | $168,511 | $46,762 |
| 2021 | 6 | 455 | 639 | $155,181 | $48,880 |
| 2020 | 10 | 697 | 801 | $118,093 | $29,159 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 329 | 491 | $125,205 | $34,873 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 42 | $14,364 | $4,466 | 31.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 96 | $1,920 | $806.40 | 42.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 25 | $2,250 | $404.60 | 18.0% |
| 82565 | Blood creatinine level | Office | 2023 | 51 | 65 | $2,275 | $318.36 | 14.0% |
| 84132 | Blood potassium level | Office | 2023 | 50 | 65 | $1,950 | $295.27 | 15.1% |
| 84295 | Blood sodium level | Office | 2023 | 50 | 64 | $1,792 | $293.79 | 16.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 37 | 41 | $1,640 | $254.92 | 15.5% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2023 | 51 | 65 | $2,145 | $245.26 | 11.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 18 | $936.00 | $141.30 | 15.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 11 | 12 | $924.00 | $124.20 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 519 | $132,345 | $37,851 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 61 | $20,862 | $6,450 | 30.9% |
| 82565 | Blood creatinine level | Office | 2022 | 48 | 64 | $2,240 | $324.28 | 14.5% |
| 84295 | Blood sodium level | Office | 2022 | 46 | 62 | $1,736 | $294.92 | 17.0% |
| 84132 | Blood potassium level | Office | 2022 | 46 | 62 | $1,860 | $291.82 | 15.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 15 | 23 | $1,196 | $289.16 | 24.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 71 | 91 | $1,820 | $268.40 | 14.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 16 | 16 | $1,440 | $252.49 | 17.5% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2022 | 48 | 64 | $2,112 | $250.08 | 11.8% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2022 | 12 | 12 | $894.60 | $203.07 | 22.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 23 | 24 | $960.00 | $153.43 | 16.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 11 | 11 | $1,045 | $132.97 | 12.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 372 | 545 | $138,975 | $43,545 | 31.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 29 | $9,918 | $3,316 | 33.4% |
About Stephanie Garner, NP
Stephanie Garner, NP is a Family healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1689074072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Garner, NP has received a total of $2,043 in payments from pharmaceutical and medical device companies, with $879.54 received in 2024. These payments were reported across 116 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,029).
As a Medicare-enrolled provider, Garner has provided services to 2,575 Medicare beneficiaries, totaling 3,433 services with total Medicare billing of $167,025. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Pinehurst, NC
- Active Since 09/04/2014
- Last Updated 01/20/2026
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1689074072
Products in Payments
- ELIQUIS (Drug) $188.32
- LifeVest (Device) $161.93
- Arcalyst (Drug) $148.46
- FUROSCIX (Drug) $144.66
- FARXIGA (Drug) $137.36
- XARELTO (Drug) $133.32
- VERQUVO (Drug) $131.77
- MULTAQ (Drug) $85.88
- JARDIANCE (Drug) $82.59
- ENTRESTO (Drug) $77.45
- OPSUMIT (Drug) $74.99
- CAMZYOS (Drug) $71.01
- Kerendia (Drug) $62.80
- (5044) MCOT (Device) $55.38
- VYNDAQEL (Drug) $48.51
- WAINUA (Drug) $42.64
- Verquvo (Drug) $42.35
- WATCHMAN Access System (Device) $35.03
- Impella (Device) $33.74
- Inpefa (Drug) $29.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Pinehurst
Holly Mcguirk, Fnp-Bc, FNP-BC
Family — Payments: $8,863
Sue Ellen Bowes
Family — Payments: $6,852
Amy Cradic, Fnp-C, FNP-C
Family — Payments: $5,556
Constance Hall, Fnp-C, FNP-C
Family — Payments: $4,548
Michael Williamson
Family — Payments: $2,867
Laura Love, Np-C, NP-C
Family — Payments: $2,479